Starling Oncology, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -22.6% | -5.4% |
| FY2022 | — | -32.5% | 0.1% |
| FY2023 | — | -23.8% | -25.6% |
| FY2024 | — | -15.3% | -16.4% |
| FY2025 | — | -7.2% | -12.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -22.6% | -5.4% |
| FY2022 | — | -32.5% | 0.1% |
| FY2023 | — | -23.8% | -25.6% |
| FY2024 | — | -15.3% | -16.4% |
| FY2025 | — | -7.2% | -12.1% |